David M. Morris

Research Triangle Park Foundation

Papers

1

Total Citations

63

H-Index

1

About

David M. Morris is a distinguished bioanalytical chemist whose work has significantly advanced the field of pharmaceutical analysis, particularly in the quantification of antiviral drugs. His most cited paper, "High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serum" (1994, 63 citations), established a robust method for measuring the HIV drug lamivudine in biological samples, enabling critical pharmacokinetic studies and therapeutic drug monitoring. This contribution reflects his expertise in developing high-performance liquid chromatography (HPLC) techniques that bridge analytical chemistry and clinical medicine. Morris’s research has provided essential tools for understanding drug metabolism and optimizing dosing regimens, impacting both preclinical and clinical research. His work is widely recognized for its precision and reproducibility, earning him a reputation as a reliable methodologist in bioanalysis. With a career focused on translating complex chemical assays into practical clinical applications, Morris has helped lay the groundwork for safer, more effective antiviral therapies. His legacy continues to inspire researchers seeking to improve drug delivery and patient outcomes through rigorous analytical science.

Research Focus

Key Achievements

1
H-Index
1
Papers
63
Total Citations
63
Avg Citations/Paper
🏆 Most Cited Paper
High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serum
63 citations · 1994
📈 Most Prolific Year: 1994 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Research Triangle Park Foundation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago